Literature DB >> 20599220

The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis.

Jill S Whitehouse1, Kevin M Riggle, David P Purpi, Alan N Mayer, Kirkwood A Pritchard, Keith T Oldham, David M Gourlay.   

Abstract

BACKGROUND: Enterocytes produce intestinal alkaline phosphatase (iAP), which detoxifies lipopolysaccharide (LPS), a mediator in necrotizing enterocolitis (NEC) pathogenesis. We hypothesize that aberrant expression or function of iAP contributes to the pathogenesis of NEC.
MATERIALS AND METHODS: Newborn Sprague Dawley rat pups were divided into three main groups. Control pups were breast fed, while two groups were exposed to intermittent hypoxia, LPS, and formula feeding for 4 d to induce NEC. Bovine iAP, with and without the presence of LPS, was administered orally to one of the NEC groups. The intestine was harvested and used to detect alkaline phosphatase (AP) activity and protein expression. Terminal ileum sections were used to grade intestinal injury and stained for AP. Comparisons were made with adult rat duodenum.
RESULTS: Compared with adult rats, control pups expressed significantly less AP protein but had 2-fold higher AP activity. NEC pup AP activity was significantly decreased compared to controls (P < or = 0.05), which paralleled both the AP protein expression and immunofluorescence assay results. Following iAP administration, immunofluorescence, protein expression, and activity of AP were significantly increased compared with NEC pups without iAP supplementation. All NEC pups had intestinal injury grades > or = 2 on a 4-point scale, while control and iAP-treated pups had grades < 0.25 (P < 0.001).
CONCLUSIONS: Enteral administration of iAP to rat pups with experimental NEC increased AP activity levels to that of controls, and appears to protect the intestine. This opens up a new area of study in NEC pathophysiology as well as a potential novel treatment strategy to prevent the development of NEC. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599220     DOI: 10.1016/j.jss.2010.04.048

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  27 in total

1.  Intestinal alkaline phosphatase to treat necrotizing enterocolitis.

Authors:  Ben E Biesterveld; Shannon M Koehler; Nathan P Heinzerling; Rebecca M Rentea; Katherine Fredrich; Scott R Welak; David M Gourlay
Journal:  J Surg Res       Date:  2015-02-19       Impact factor: 2.192

2.  Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca Maria Rentea; Scott R Welak; Katherine Fredrich; Deborah Donohoe; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay; Jennifer L Liedel
Journal:  Eur J Pediatr Surg       Date:  2012-11-19       Impact factor: 2.191

Review 3.  Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Authors:  Jason Fawley; David M Gourlay
Journal:  J Surg Res       Date:  2015-12-17       Impact factor: 2.192

4.  Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain.

Authors:  Ye Yang; José Luis Millán; Joan Mecsas; Karen Guillemin
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

5.  Intestinal alkaline phosphatase administration in newborns decreases systemic inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay
Journal:  J Surg Res       Date:  2012-06-01       Impact factor: 2.192

6.  The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitis.

Authors:  Richard Kampanatkosol; Tricia Thomson; Omar Habeeb; Loretto Glynn; Phillip J Dechristopher; Sherri Yong; Walter Jeske; Akhil Maheshwari; Jonathan Muraskas
Journal:  J Pediatr Surg       Date:  2013-11-21       Impact factor: 2.545

Review 7.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

8.  Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis.

Authors:  Kevin M Riggle; Rebecca M Rentea; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay
Journal:  J Surg Res       Date:  2012-11-08       Impact factor: 2.192

Review 9.  Enteral Feeding Interventions in the Prevention of Necrotizing Enterocolitis: A Systematic Review of Experimental and Clinical Studies.

Authors:  Ilse H de Lange; Charlotte van Gorp; Laurens D Eeftinck Schattenkerk; Wim G van Gemert; Joep P M Derikx; Tim G A M Wolfs
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

10.  Enteral intestinal alkaline phosphatase administration in newborns decreases iNOS expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Kirkwood Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.